These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34174409)

  • 1. Systematic review and meta-analysis to explore optimal therapeutic range of vancomycin trough level for infected paediatric patients with Gram-positive pathogens to reduce mortality and nephrotoxicity risk.
    Kato H; Hagihara M; Okudaira M; Asai N; Koizumi Y; Yamagishi Y; Mikamo H
    Int J Antimicrob Agents; 2021 Aug; 58(2):106393. PubMed ID: 34174409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Drug Monitoring Coupled With Bayesian Forecasting Could Prevent Vancomycin-Associated Nephrotoxicity in Renal Insufficiency Patients: A Prospective Study and Pharmacoeconomic Analysis.
    Zhang Y; Wang T; Zhang D; You H; Dong Y; Liu Y; Du Q; Sun D; Zhang T; Dong Y
    Ther Drug Monit; 2020 Aug; 42(4):600-609. PubMed ID: 32097248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of vancomycin treatment outcomes in Chinese paediatric patients with suspected Gram-positive infection.
    Wei WX; Qin XL; Cheng DH; Lu H; Liu TT
    J Clin Pharm Ther; 2016 Dec; 41(6):650-656. PubMed ID: 27578443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of low vs. high vancomycin trough level on the clinical outcomes of adult patients with sepsis or gram-positive bacterial infections: a systematic review and meta-analysis.
    Chander S; Kumari R; Wang HY; Mohammed YN; Parkash O; Lohana S; Sorath F; Lohana AC; Sadarat F; Shiwlani S
    BMC Infect Dis; 2024 Oct; 24(1):1114. PubMed ID: 39375599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prospective Multicenter Clinical Observational Study on Vancomycin Efficiency and Safety With Therapeutic Drug Monitoring.
    Liang X; Fan Y; Yang M; Zhang J; Wu J; Yu J; Tao J; Lu G; Zhang H; Wang R; Wen X; Li H; Zhang F; Hang J; Shen L; Zhang Z; Lin Q; Fu F; Wu S; Shen B; Huang W; Chang C; Zhang H; Huang Q; Shi Y; Ren H; Yuan Q; Song X; Luo X; Zhang H
    Clin Infect Dis; 2018 Nov; 67(suppl_2):S249-S255. PubMed ID: 30423040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High versus low vancomycin serum trough regimen for Gram-positive infections: a meta-analysis.
    Meng L; Fang Y; Chen Y; Zhu H; Long R
    J Chemother; 2015 Aug; 27(4):213-20. PubMed ID: 24641266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis.
    Cataldo MA; Tacconelli E; Grilli E; Pea F; Petrosillo N
    J Antimicrob Chemother; 2012 Jan; 67(1):17-24. PubMed ID: 22028203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between Vancomycin Trough Serum Concentrations and Clinical Outcomes in Children: a Systematic Review and Meta-Analysis.
    Cao L; Li Z; Zhang P; Yong S
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0013822. PubMed ID: 35862741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The optimal trough-guided monitoring of vancomycin in children: Systematic review and meta-analyses.
    Moriyama H; Tsutsuura M; Kojima N; Mizukami Y; Tashiro S; Osa S; Enoki Y; Taguchi K; Oda K; Fujii S; Takahashi Y; Hamada Y; Kimura T; Takesue Y; Matsumoto K
    J Infect Chemother; 2021 May; 27(5):781-785. PubMed ID: 33563525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin efficiency and safety of a dosage of 40-60 mg/kg/d and corresponding trough concentrations in children with Gram-positive bacterial sepsis.
    Peng L; Guo Z; Zhang G; Tian X; Gu R; Li Q; Li Y; Luo Z
    Front Cell Infect Microbiol; 2023; 13():1117717. PubMed ID: 37065209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis.
    Ye ZK; Tang HL; Zhai SD
    PLoS One; 2013; 8(10):e77169. PubMed ID: 24204764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Initial Trough Concentrations of Vancomycin with Outcomes in Pediatric Patients with Gram-Positive Bacterial Infection.
    Kondo M; Nakagawa S; Orii S; Itohara K; Sugimoto M; Omura T; Sato Y; Imai S; Yonezawa A; Nakagawa T; Matsubara K
    Biol Pharm Bull; 2020; 43(10):1463-1468. PubMed ID: 32999156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Vancomycin on Gram-Positive Bacterial Infection in Elderly Critical Patients and Risk Factors Associated With Nephrotoxicity.
    Huang M; Wu H; Zhou J; Xu M; Zhou S
    Arch Iran Med; 2018 Aug; 21(8):349-355. PubMed ID: 30113856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin serum trough concentration vs. clinical outcome in patients with gram-positive infection: a retrospective analysis.
    Cao G; Liang X; Zhang J; Zhou Y; Wu J; Zhang Y; Chen Y; Huang J; Liu X; Yu J
    J Clin Pharm Ther; 2015 Dec; 40(6):640-4. PubMed ID: 26383121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis.
    Steinmetz T; Eliakim-Raz N; Goldberg E; Leibovici L; Yahav D
    Clin Microbiol Infect; 2015 Jul; 21(7):665-73. PubMed ID: 25887712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of vancomycin nephrotoxicity when administered to outpatients as a continuous 24-hour infusion.
    Chambers ST; Long M; Gardiner SJ; Chin PKL; Yi M; Dalton SC; Drennan PG; Metcalf SCL
    Int J Antimicrob Agents; 2020 Jun; 55(6):105972. PubMed ID: 32298746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentration.
    Oda K; Jono H; Nosaka K; Saito H
    Int J Antimicrob Agents; 2020 Oct; 56(4):106109. PubMed ID: 32721597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin-associated nephrotoxicity in non-critically ill patients admitted in a Brazilian public hospital: A prospective cohort study.
    de Almeida CDC; Simões E Silva AC; de Queiroz Oliveira JA; Batista ISF; Pereira FH; Gonçalves JE; Nobre V; Martins MAP
    PLoS One; 2019; 14(9):e0222095. PubMed ID: 31487314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotoxicity in patients with vancomycin trough concentrations of 15-20 μg/ml in a pediatric intensive care unit.
    Cies JJ; Shankar V
    Pharmacotherapy; 2013 Apr; 33(4):392-400. PubMed ID: 23471688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
    Lodise TP; Patel N; Lomaestro BM; Rodvold KA; Drusano GL
    Clin Infect Dis; 2009 Aug; 49(4):507-14. PubMed ID: 19586413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.